Literature DB >> 10331358

Effective adenovirus-mediated gene expression in adult murine skeletal muscle.

A Ishii1, Y Hagiwara, Y Saito, K Yamamoto, K Yuasa, Y Sato, K Arahata, S Shoji, I Nonaka, I Saito, Y Nabeshima, S Takeda.   

Abstract

We established an efficient method for obtaining expression of a foreign marker gene transferred in vitro into myoblasts and in vivo into adult mouse skeletal muscles using adenovirus vector. After infection of the C2 myoblasts with the adenovirus vector containing the beta-actin promoter with cytomegalovirus (CMV) enhancer (CAG promoter) AxCALacZ, significantly greater number of cells express beta-galactosidase when compared with the adenovirus vector expressing the lacZ gene under the control of the SR alpha viral terminal repeat promoter (AxSRLacZL) or the myosin heavy chain (MHC) IIB promoter (AxMHCLacZ). We also injected AxCALacZ into the skeletal muscles of 5- to 6-week-old C57BL/10 mice and determined that more than 60% of their muscle fibers expressed the lacZ gene 7 days after injection. The CAG promoter may have application in the development of gene therapy for Duchenne muscular dystrophy (DMD) using adenovirus vector.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331358     DOI: 10.1002/(sici)1097-4598(199905)22:5<592::aid-mus7>3.0.co;2-2

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  5 in total

1.  Imaging of human sodium-iodide symporter gene expression mediated by recombinant adenovirus in skeletal muscle of living rats.

Authors:  Hyun Suk Yang; Heuiran Lee; Sung Jin Kim; Won Woo Lee; You-Jung Yang; Dae Hyuk Moon; Seong-Wook Park
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-06-25       Impact factor: 9.236

2.  Muscle-specific overexpression of the adenovirus primary receptor CAR overcomes low efficiency of gene transfer to mature skeletal muscle.

Authors:  J Nalbantoglu; N Larochelle; E Wolf; G Karpati; H Lochmuller; P C Holland
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

3.  Transduction efficiency and immune response associated with the administration of AAV8 vector into dog skeletal muscle.

Authors:  Sachiko Ohshima; Jin-Hong Shin; Katsutoshi Yuasa; Akiyo Nishiyama; Junichi Kira; Takashi Okada; Shin'ichi Takeda
Journal:  Mol Ther       Date:  2008-10-21       Impact factor: 11.454

4.  Pharmacogenetic heterogeneity of transgene expression in muscle and tumours.

Authors:  Pierre Lefesvre; Joline Attema; Dirk van Bekkum
Journal:  BMC Pharmacol       Date:  2003-08-28

5.  rAAV8 and rAAV9-Mediated Long-Term Muscle Transduction with Tacrolimus (FK506) in Non-Human Primates.

Authors:  Akiko Ishii; Hironori Okada; Hiromi Hayashita-Kinoh; Jin-Hong Shin; Akira Tamaoka; Takashi Okada; Shin'ichi Takeda
Journal:  Mol Ther Methods Clin Dev       Date:  2020-05-22       Impact factor: 6.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.